Cargando…
Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times
With the emergence of the novel coronavirus disease (COVID-19) viral pandemic, there is uncertainty whether biologic agents for psoriasis may place patients at a higher risk for infection or more severe disease course. This commentary offers patient counseling recommendations based on the current av...
Autores principales: | Brownstone, Nicholas D., Thibodeaux, Quinn G., Reddy, Vidhatha D., Myers, Bridget A., Chan, Stephanie Y., Bhutani, Tina, Liao, Wilson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160052/ https://www.ncbi.nlm.nih.gov/pubmed/32300516 http://dx.doi.org/10.1007/s13555-020-00377-9 |
Ejemplares similares
-
Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Brownstone, Nicholas D., et al.
Publicado: (2020) -
Psoriasis Vulgaris Successfully Treated with Goeckerman Treatment at Home: A Patient and Physician’s Experience
por: Reddy, Vidhatha, et al.
Publicado: (2020) -
Machine Learning in Dermatology: Current Applications, Opportunities, and Limitations
por: Chan, Stephanie, et al.
Publicado: (2020) -
High-dose doxepin for the treatment of chronic, intractable scalp pruritus
por: Chan, Stephanie, et al.
Publicado: (2020) -
Dual biologic therapy for recalcitrant psoriasis and psoriatic arthritis
por: Thibodeaux, Quinn, et al.
Publicado: (2019)